期刊
GENE THERAPY
卷 18, 期 3, 页码 220-224出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2010.123
关键词
anaplastic large cell lymphoma (ALCL); cell transfection; gene silencing; DNA minicircle
类别
资金
- Burroughs Welcome Fund
- National Institutes of Health (NIH) [K22CA113493, RO1A1054830]
- TMHRI CTS Award
This work illustrates the utility of Minivector DNA, a non-viral, supercoiled gene therapy vector incorporating short hairpin RNA from an H1 promoter. Minivector DNA is superior to both plasmid DNA and small interfering RNA (siRNA) in that it has improved biostability while maintaining high cell transfection efficiency and gene silencing capacity. Minivector DNAs were stable for over 48 h in human serum, as compared with only 0.5 and 2 h for siRNA and plasmid, respectively. Although all three nucleic acids exhibited similar transfection efficiencies in easily transfected adhesion fibroblasts cells, only Minivector DNAs and siRNA were capable of transfecting difficult-to-transfect suspension lymphoma cells. Minivector DNA and siRNA were capable of silencing the gene encoding anaplastic lymphoma kinase, a key pathogenic factor of human anaplastic large cell lymphoma, and this silencing caused inhibition of the lymphoma cells. Based on these results, Minivector DNAs are a promising new gene therapy tool. Gene Therapy (2011) 18, 220-224; doi:10.1038/gt.2010.123; published online 21 October 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据